๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma

โœ Scribed by M. Ernest Marshall; Michael K. Wolf; E. David Crawford; Sarah Taylor; Brent Blumenstein; Robert Flanigan; Fredrick J. Meyers; Harry E. Hynes; Bart Barlogie; Mario Eisenberger

Publisher
Springer US
Year
1993
Tongue
English
Weight
185 KB
Volume
11
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of Didemnin B in patients
Phase II trial of Didemnin B in patients with advanced renal cell carcinoma
โœ Robert Motzer; Howard Scher; Dean Bajorin; Cora Sternberg; George J. Bosl ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 115 KB

Twenty-three patients with advanced renal cell cancer were treated with Didemnin B. One partial response was achieved (5070) in 21 evaluable patients. An allergic reaction was noted in four patients including one patient with anaphylaxis. Didemnin B is not recommended in the treatment of renal cell

Phase II trial of echinomycin in advance
Phase II trial of echinomycin in advanced soft tissue sarcomas
โœ Sarah A. Taylor; Barbara Metch; Stanley P. Balcerzak; Karl H. Hanson ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 232 KB

Thirty-four patients with advanced soft tissue sarcomas were entered in a phase II trial of echinomycin. Patients received 1.2 mg/m 2 intravenously (i.v.) weekly times four followed by a two week rest period. There were no objective responses. Dose limiting toxicity was gastrointestinal. Echinomycin